Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
XBiotech Inc
XBIT | US
7.57
USD0.02
0.26%
XBIT | US
About XBiotech Inc
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
21/10/2024
Close
7.57
Open
7.48
High
7.60
Low
7.45
XBiotech Inc. a biopharmaceutical company discovers develops and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical conditions such as cancer stroke heart attack or arthritis; and mediates tissue breakdown angiogenesis the formation of blood clots malaise muscle wasting and inflammation. The company was incorporated in 2005 and is headquartered in Austin Texas.
View LessXBIT | US
Risk
59.5
Sharpe
1.13
Luna's Score
46/100
Recommendation
Hold
Luna says (XBIT | US)
What's Working
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
What's not Working
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Declining Revenue (< 0%)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
10 days
57.4%1 month
59.5%3 months
78.2%6 months
77.7%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
1.17
Debt to equity
0.05
Debt to assets
0.05
Ent. to EBITDA
-1.60
Ent. to rev.
24.05
PEG
-
Other Fundamentals
EBITDA
-41.19M
MarketCap
230.61M
MarketCap(USD)
230.61M
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-93.30
Ret. on equity
-16.44
Short ratio
17.11
Short perc.
5.19
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Range10D
1.01
Range1M
1.68
Range3M
2.36
Volumes: Market Activity
Rel. volume
0.54
Price X volume
142.49K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -1.60 | 0.53 | Cheaper |
| Ent. to Revenue | 24.05 | 3,967.00 | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 1.17 | 15.55 | Cheaper |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 78.23 | 72.80 | Par |
| Debt to Equity | 0.05 | -1.23 | Expensive |
| Debt to Assets | 0.05 | 0.25 | Cheaper |
| Market Cap | 230.61M | 3.66B | Emerging |
